Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|July 2, 2021
Filamin A Regulates Cardiovascular RemodelingSashidar Bandaru, Chandu Ala, Alex-Xianghua Zhou, et al.Life Sciences|March 8, 2025
A critique review of fetal hemoglobin modulators through targeting epigenetic regulators for the treatment of sickle cell diseaseChandu Ala, Sivaprakash Ramalingam, Chandra Sekhar Kondapalli Venkata Gowri, et al.Journal of Biomolecular Structure & Dynamics|April 16, 2023
Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approachesChandu Ala, Renuka Parshuram Joshi, Pragya Gupta, et al.Computational Biology and Chemistry|November 29, 2024
Pharmacoinformatics-based prediction of Checkpoint kinase-1 inhibitors from Momordica charantia Linn. for cancerSubramanian Haripriya, Muniyandi Vijayalakshmi, Chandu Ala, et al.Journal of Biomolecular Structure & Dynamics|August 16, 2023
Pharmacoinformatics-based identification of phytochemicals from Solanum torvum Swartz. fruits as potential inhibitors for MAPK14 proteinPriya Petchimuthu, Chandu Ala, Selvaraj Kunjiappan, et al.Anticancer Research|March 31, 2018
Blocking the Cleavage of Filamin A by Calpain Inhibitor Decreases Tumor Cell GrowthReza Salimi, Sashidhar Bandaru, Sravani Devarakonda, et al.RSC Medicinal Chemistry|March 26, 2025
Thiochromenes and thiochromanes: a comprehensive review of their diverse biological activities and structure-activity relationship (SAR) insightsJatin, Solai Murugappan, Shivani Kirad, et al.Computers in Biology and Medicine|June 10, 2025
Exploring potential allosteric activators of pyruvate Kinase: Insights from molecular docking, DFT and dynamics simulation studiesChandu Ala, Ishan Shrinivas Shet Honavarkar, Raul Sheldon Pinto, et al.Archiv Der Pharmazie|July 20, 2024
A critical review of therapeutic interventions in sickle cell disease: Progress and challengesChandu Ala, Renuka Parshuram Joshi, Pragya Gupta, et al.Scientific Reports|October 13, 2019
The MTH1 inhibitor TH588 is a microtubule-modulating agent that eliminates cancer cells by activating the mitotic surveillance pathwayNadia Gul, Joakim Karlsson, Carolina Tängemo, et al.Pageof 2